MILESTONE SCIENTIFIC Business Summary

Milestone Scientific Inc. (MLSS) is a biomedical technology firm that develops and commercializes patented, computer-controlled drug delivery systems designed to provide precise, painless injections. The company generates revenue through a transaction-based model consisting of capital equipment sales (instruments) and high-margin, recurring sales of single-use disposable handpieces. Its operations are divided into two primary segments: Dental, which markets The Wand/STA Single Tooth Anesthesia system, and Medical, which focuses on the CompuFlo Epidural System for pain management and regional anesthesia. Milestone is currently executing a strategic shift toward a direct-to-practice e-commerce sales model to enhance gross margins and accelerate market adoption of its proprietary Dynamic Pressure Sensing (DPS) technology. Within the medical device landscape, Milestone competes with firms such as Sensus Healthcare (SRTS), Retractable Technologies (RVP), and Precision Optics Corporation (POCI), positioning itself as a niche innovator aiming to replace traditional manual syringes with digitally regulated, pressure-monitored delivery platforms. The company’s leadership is anchored by Founder and Vice Chairman Leonard Osser and Clinical Director Dr. Mark Hochman, the latter of whom is a primary inventor of the firm’s core technology. As of February 2026, the executive team is led by Chief Executive Officer Eric C. Hines, who was appointed in August 2025 and brings over 25 years of experience in scaling sales-driven enterprise organizations, including a previous tenure as President of North America at Ex Libris (a Clarivate company). Financial operations are overseen by CFO Peter Milligan, a veteran executive with a pedigree that includes leadership roles at Melinta Therapeutics and Exelis. The Board of Directors is chaired by Neal Goldman, founder of Goldman Capital Management, and recently added Dr. Dawood Sayed, a prominent expert in interventional pain medicine, to bolster the commercialization strategy for the CompuFlo medical platform.